Friday 6 November 2026
Export ICUI’s income statement to Excel — free account
ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
172.03
4.38
+2.61%
Follow ICUI
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 6 |
| 0.04% | 2.26% | 1.41% | 2.79% | ||
| 0.02% | 1.13% | 0.74% | 1.50% | ||
ROIC |
0.86% | 0.88% | 1.46% | 2.27% | |
Return on Tangible Assets |
0.06% | 4.06% | 2.60% | 5.25% | |
Average Days of Receivables |
29.53 | 34.03 | 31.02 | 34.49 | |
Free Cash Flow per Share |
3.69 | 3.31 | 6.12 | 10.89 | |
Free Cash Flow |
90.89 | 82.08 | 152.88 | 272.24 | |
Capital Expenditures |
(88.96) | (85.35) | (83.49) | (7.01) | |
| Other line items | |||||
Cash ROIC |
2.45% | 2.23% | 4.15% | 7.47% | |
Accounts Receivable Turnover |
12.28 | 11.60 | 11.90 | 10.98 | |
Accounts Payable Turnover |
9.32 | 7.55 | 8.27 | 8.29 | |
Inventory Turnover |
2.35 | 2.24 | 2.15 | 2.12 | |
Average Days of Payables |
39.98 | 47.44 | 41.42 | 40.02 | |
Days of Inventory on Hand |
159.51 | 165.12 | 168.67 | 169.97 | |
Tax Rate |
(0.56) | 3.26 | 41.05 | 0.00 | |
Research and Development Expense of Revenue |
3.92% | 3.96% | 4.00% | 3.98% | |
Selling, General and Administrative Expense of Revenue |
28.02% | 28.86% | 28.48% | 28.25% | |
Share Based Compensation of Revenue |
2.50% | 2.67% | 2.55% | 2.36% | |
Interest Coverage |
0.52 | 0.56 | 0.99 | — | |
Operating CF/Net income |
245.69 | 3.61 | 7.86 | 4.63 | |
Depreciation/Fixed assets |
0.46 | 0.46 | 0.46 | 0.46 | |
Capex/Depreciation |
(0.43) | (0.41) | (0.41) | (0.03) | |
Revenue per Share |
90.55 | 87.09 | 86.38 | 87.30 | |
Operating CF per Share |
7.30 | 6.76 | 9.45 | 11.17 | |
Capex per Share |
(3.61) | (3.45) | (3.34) | (0.28) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026